Physician profile
Anthony L Howard
NPI 1225102908
$1,753.45
in general payments reported to CMS, 2019-2025
24 companies · $69.22 in 2025
The $69.22 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $343 · 2021: $196 · 2022: $212 · 2023: $267 · 2024: $47.31 · 2025: $69.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $345.88 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $235.03 | 2019-2023 | |
| Abbvie INC. | $182.39 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $162.49 | 2022-2023 | Austedo, Austedo Xr |
| Neurocrine Biosciences, INC. | $137.47 | 2022-2025 | Ingrezza |
| Novo Nordisk INC | $89.16 | 2019-2023 | |
| Lilly USA, LLC | $74.31 | 2019-2025 | Mounjaro, Zepbound |
| Avanir Pharmaceuticals, INC. | $66.45 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $63.99 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $63.32 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $55.90 | 2020-2021 | |
| Lundbeck LLC | $44.85 | 2023-2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.19 | 2021-2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $29.16 | 2020 | |
| Sun Pharmaceutical Industries INC. | $27.78 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $21.56 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.65 | 2019 | |
| Abbott Laboratories | $18.05 | 2022 | |
| Exact Sciences Corporation | $17.32 | 2025 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $15.10 | 2020 | |
| Daiichi Sankyo INC. | $14.12 | 2020 | |
| Allergan, INC. | $13.74 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.45 | 2019 | |
| Biogen, INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.